GlucoTrack, Inc.
GlucoTrack, Inc. (GCTK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GCTK · as of Jun 8, 2026
Key Statistics
Explore GlucoTrack, Inc. Data
gctk stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
gctk competitorsGCTK
AKAN
BBLG
BGMS
DHAI
HSCSStock Performance
Full HistoryAbout GlucoTrack, Inc.
GlucoTrack, Inc. a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and inte…
what is glucotrack, inc. · gctk stock overview · glucotrack, inc. company profile · who is glucotrack, inc. ceo · gctk NASDAQ · glucotrack, inc. headquarters · glucotrack, inc. business segments
About Stock Overview & Key Data
GlucoTrack, Inc. (GCTK) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Apr 25, 2013. As of the latest trading session, GCTK stock price is $0.61, with a market capitalization of $329,635. The stock has returned -93.59% over the past 12 months and -84.99% year-to-date.
In fiscal year 2025, GlucoTrack, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, GlucoTrack, Inc. (GCTK) stock price is $0.61. The stock is traded on NASDAQ under the ticker symbol GCTK. The 52-week range is $0.43 – $15.90.